Crossmark

Exploring the impact of primary care utilization and health information exchange upon treatment patterns and clinical outcomes of glioblastoma patients

Crossref DOI link: https://doi.org/10.1007/s11060-024-04677-4

Published Online: 2024-04-25

Published Print: 2024-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Parker, Megan

Kazemi, Foad

Ahmed, A. Karim

Kuo, Cathleen C.

Nair, Sumil K.

Rincon-Torroella, Jordina

Jackson, Christopher

Gallia, Gary

Bettegowda, Chetan

Weingart, Jon

Brem, Henry

Mukherjee, Debraj
License Information

Text and Data Mining valid from 2024-04-25

Version of Record valid from 2024-04-25
More Information

Article History

Received: 1 March 2024

Accepted: 5 April 2024

First Online: 25 April 2024

Declarations

:

: This study was approved by our Institutional Review Board (IRB00331509).

: Patient informed consent was waived for this retrospective study by our Institutional Review Board.

: CB is a consultant for Depuy-Synthes, Bionaut Labs, Haystack Oncology, Privo Technologies and Galectin Therapeutics. CB is a co-founder of OrisDx and Belay Diagnostics.

Document is current

Any future updates will be listed below